002688.SZ
金河生物
SZSE · Healthcare · C 制造业 · CN
CNY 5.18
+0.19%Margins
Gross margin
33.9%
EBITDA margin
9.3%
EBIT margin
2.0%
Net margin
1.3%
FCF margin
3.1%
1.7%
Return on equity
0.7%
Return on assets
1.5%
Return on invested capital
0.53x
Asset turnover
CNY 429.7M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026